Dr. Stephanie Venn-Watson

It does. And so it's just the, you know, kind of what you're going through here is it's a cycle that feeds on itself. So when we have, you know, oxygen and we have two fragile fatty acids in our cell membrane, and these are fatty acids that have double bonds. That's what the secret of C15 is that it's a sturdy fat that has no double bonds. So It is completely resistant to this oxidative stress.

It does. And so it's just the, you know, kind of what you're going through here is it's a cycle that feeds on itself. So when we have, you know, oxygen and we have two fragile fatty acids in our cell membrane, and these are fatty acids that have double bonds. That's what the secret of C15 is that it's a sturdy fat that has no double bonds. So It is completely resistant to this oxidative stress.

But if we have cell membranes with too many fragile fatty acids in it, oxygen goes in and attacks it. It makes it weak. The cell falls apart. That happens in, like you said, both the cell membrane or mitochondria, the powerhouses of our cells. That then sets up the cell for getting fragile, hence cellular fragility syndrome.

But if we have cell membranes with too many fragile fatty acids in it, oxygen goes in and attacks it. It makes it weak. The cell falls apart. That happens in, like you said, both the cell membrane or mitochondria, the powerhouses of our cells. That then sets up the cell for getting fragile, hence cellular fragility syndrome.

And that incites release of pro-inflammatory cytokines, this inflammatory response, and in fact, a whole new form of cell death called feroptosis. And it's entirely a new way our cells are dying due to this syndrome of lipid peroxidation, oxidative stress in our cell membranes.

And that incites release of pro-inflammatory cytokines, this inflammatory response, and in fact, a whole new form of cell death called feroptosis. And it's entirely a new way our cells are dying due to this syndrome of lipid peroxidation, oxidative stress in our cell membranes.

Right. So it goes really into the deep dive of if you're going to call a book the longevity nutrient, which, you know, this was actually Simon and Schuster reached out to me last summer, Dr. Drew. And they've been following the story and the science. They're getting out over 100 peer reviewed papers on C15 is this healthy saturated fat.

Right. So it goes really into the deep dive of if you're going to call a book the longevity nutrient, which, you know, this was actually Simon and Schuster reached out to me last summer, Dr. Drew. And they've been following the story and the science. They're getting out over 100 peer reviewed papers on C15 is this healthy saturated fat.

You still ask a lot of people today and most people have never heard of C50 and let alone that not all saturated fats are bad. So Simon and Schuster reached out and they said, this is a book, like this is a movement. And we really want you to be able to write this book, help support and get it out to the world.

You still ask a lot of people today and most people have never heard of C50 and let alone that not all saturated fats are bad. So Simon and Schuster reached out and they said, this is a book, like this is a movement. And we really want you to be able to write this book, help support and get it out to the world.

It's the story for sure. And so it's a, it's, it's the way they put is a really engaging way to explaining the science, but all through the story of, you know, starting with the dolphins and then just being able to trace the different investigations that were happening of, you know, in Japan and Korea, they were working on how C-15 has anti-cancer properties in Italy.

It's the story for sure. And so it's a, it's, it's the way they put is a really engaging way to explaining the science, but all through the story of, you know, starting with the dolphins and then just being able to trace the different investigations that were happening of, you know, in Japan and Korea, they were working on how C-15 has anti-cancer properties in Italy.

They were working on different components like throughout the world, trying, tracking all of these different studies that were happening, all leading to the same conclusion, which is that C15 is the longevity nutrient outperforming even molecules like rapamycin, you know, that we hear so much about as extending longevity.

They were working on different components like throughout the world, trying, tracking all of these different studies that were happening, all leading to the same conclusion, which is that C15 is the longevity nutrient outperforming even molecules like rapamycin, you know, that we hear so much about as extending longevity.

The book really walks us through this very compelling story that whether it's large scale epidemiological studies, receptor-based, what's called mechanisms of action, how it works, how it's helping prevent and slow heart disease, type 2 diabetes, different types of cancer, and all the science behind it. But again, in a very compelling, friendly, reader-friendly way.

The book really walks us through this very compelling story that whether it's large scale epidemiological studies, receptor-based, what's called mechanisms of action, how it works, how it's helping prevent and slow heart disease, type 2 diabetes, different types of cancer, and all the science behind it. But again, in a very compelling, friendly, reader-friendly way.

We did. And in fact, it was triggered by, this study was inspired by Dr. Nick Shork, who's head of the prestigious Longevity Consortium. And Nick said, hey, with all of these properties of C15 that you're showing as this essential fatty acid, it's anti-inflammatory, anti-fibrotic, anti-cancer, antioxidant, even antimicrobial.

We did. And in fact, it was triggered by, this study was inspired by Dr. Nick Shork, who's head of the prestigious Longevity Consortium. And Nick said, hey, with all of these properties of C15 that you're showing as this essential fatty acid, it's anti-inflammatory, anti-fibrotic, anti-cancer, antioxidant, even antimicrobial.

He said, I bet I'd be curious to see how it did if you went head to head against rapamycin and metformin, two of the leading longevity molecules. And so we use this really industry standard, robust third party study. panel where it takes 12 different human cell systems mimicking various disease states, heart disease, liver disease, lung disease.

He said, I bet I'd be curious to see how it did if you went head to head against rapamycin and metformin, two of the leading longevity molecules. And so we use this really industry standard, robust third party study. panel where it takes 12 different human cell systems mimicking various disease states, heart disease, liver disease, lung disease.